The 20 Best Pleuropulmonary Blastoma Doctors Near Me in Ann Arbor, MI

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Rishindra M. Reddy, M.D., is the José José Alvarez Research Professor in Thoracic Surgery. He was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St. Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education.Clinical Specialization: Dr. Reddy's clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques and robotics surgery, esophageal diseases, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Hiatal Hernia, Esophageal Cancer, Endoscopy, and Lung Transplant. Dr. Reddy is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

James Fugazzi is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Fugazzi is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Fugazzi is board certified in Radiation Oncology.

Richard Cattaneo is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Cattaneo is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Tareq Baghdadi is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Baghdadi is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Tissue Biopsy, and Bone Marrow Aspiration.

Walter Sahijdak is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Sahijdak is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Samir Narayan is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Narayan is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Posterior Fossa Tumor.

Eva Bieniek is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Bieniek is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer.

Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Regenbogen is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.

Mario Lacerna is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lacerna is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Lacerna is board certified in Radiation Oncology.

Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.

Nithya Ramnath is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Ramnath is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

William R. Lynch, M.D., is the Associate Professor of Surgery for the Section of Thoracic Surgery in the clinical track in the Department of Surgery, Section of Thoracic Surgery. He will also provide services at the Ann Arbor Veterans Administration Hospital and have a dry appointment in the College of Engineering, Department of Biomedical Engineering.Principal responsibilities include clinical care, teaching, clinical research and program development, particularly implementation of ex vivo lung perfusion and other means of advanced donor organ management into our pulmonary transplantation program. Dr. Lynch will be mentored with Dr. Robert Bartlett. Primary research responsibilities are conducting independent scholarly investigations in the ECMO and critical care. Dr. Lynch has served as Chairman-Elect for the ELSO Steering Committee since 2010, and has had eight publications in peer-reviewed journals.Dr. Lynch received his Medical Degree (1994) from the University of Michigan, and completed his General Surgery residency (2000) at Milton S. Hershey Medical Center, Hershey, Pennsylvania. He completed his Thoracic Surgery residency at the University of Michigan in 2003. He was a Fellow in Extracorporeal Life Support (1998) and in Surgical Critical Care (1999) at the University of Michigan and more recently had a Fellowship in Lung Transplantation (2011) with the Toronto Lung Transplant Group, Toronto, Ontario. Clinical Specialization: Dr. Lynch specializes in all aspects of general thoracic surgery including pulmonary transplantation and thoracic oncology. Dr. Lynch is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Pleurisy, Pleuropulmonary Blastoma, Lung Transplant, and Endoscopy. Dr. Lynch is board certified in Surgery, Thoracic & Cardiac Surgery, and Surgical Critical Care.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.